IndiaTickerMercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Company dossier
Mercury Laboratories
BSE:MERCURYLAB · ISIN INE947G01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Mercury Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25, 2026BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Unaudited Financial Results For The Quarter Ended On June 30, 2026BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended On June 30, 2026.BSE · financial results · pdf
Archived filing Mercury Laboratories Ltd - 538964 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Archived filing Mercury Laboratories Ltd - 538964 - Closure of Trading WindowBSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Corrigendum To Audited Financial Results Of The Company For The Quarter And Financial Year Ended On March 31, 2026BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outocme Of Board Meeting Held On May 29, 2025BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Book Closure Intimation For AGMBSE · corporate action · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Audited Financial Results For The Year Ended On March 31, 2026BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year
Ended On March 31, 2026 Together With The Draft Directors' Report.BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Intimation To Shareholders Relating To Transfer Of Equity Shares To IEPF AuthorityBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Results- Financial Results As On December 31, 2025BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of Board Meeting Held On 11.02.2026BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2025BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Closure of Trading WindowBSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Unaudited Financial Results For The Quarter And Half Year Ended On September 2025BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Updates On New Small Volume Parenteral (Svps) Plant At JarodBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of Board Meeting Held On November 11, 2025BSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2025 Scheduled To Be Held On November 11, 2025BSE · financial results · pdf
Source filing Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Mercury Laboratories Ltd - 538964 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing